Vaxxas, a clinical-stage biotechnology company, has expanded its global intellectual property portfolio to 42 patents, supporting its exclusive claim ...
A map that has been making the rounds suggests that about a quarter of Karnataka’s population may live in the Bengaluru metropolitan area, potentially ranking it as the third most populous city in ...